Epilepsy Clinical Trials in Miami, Florida

5 studies are recruiting for epilepsy in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Diagnosing Epilepsy To EffeCT Change

    The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This resear…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    Nicklaus Children's Hospital, Miami, Florida
    Locations
    21 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110337 on ClinicalTrials.gov

  2. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    Nicklaus Children's Hospital, Miami, Florida
    Locations
    18 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110454 on ClinicalTrials.gov

  3. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

    This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Serenity Research Center, LLC, Miami, Florida
    Locations
    11 in total
    Run by
    Rapport Therapeutics Inc.

    See if you can join NCT07594119 on ClinicalTrials.gov

  4. Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

    This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    Visionary Investigators Network, Miami, Florida
    Locations
    10 in total
    Run by
    Supernus Pharmaceuticals, Inc.

    See if you can join NCT05518578 on ClinicalTrials.gov

  5. Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

    Methylphenidate (MPH) is a stimulant, FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD). It is unknown, however, if stimulants would be of benefit for memory and thinking problems due to epilepsy. In this study, participants will be assigned randomly (i.e., by flip o…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Miami VA Healthcare System, Miami, FL, Miami, Florida
    Locations
    4 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04419272 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.